Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02962128 · ClinicalTrials.gov registry record · NA
Role of Polyunsaturated Fatty Acids (PUFA)-Gene Interactions in Heath Disparities
A NA study of Fatty Acid-Gene Interactions, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- NA
- Development phase
- 80
- Enrollment target
- 1
- Study location
NCT02962128: Completed NA study of Fatty Acid-Gene Interactions, sponsored by Wake Forest University Health Sciences.
NCT02962128 is a NA study of Fatty Acid-Gene Interactions that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 80 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02962128, a NA study of Fatty Acid-Gene Interactions, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
- 1
- Study location
Study Summary
A randomized, clinical trial to provide the first comprehensive investigation of the role of fatty acid desaturate (FADS) genetic determinants on PUFA biosynthesis and metabolism as well as levels of inflammatory markers in a controlled dietary environment using two (low and high linoleic acid) parallel diets.
Primary Outcome
The primary outcome is the measurement of the change in PUFAs at 12 weeks. Biological specimens (urine and blood) will be collected from each subject at the beginning of the dietary intervention and at 4 week intervals. The primary outcome will be the measured difference between baseline and final PUFA levels before and after the diet.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT High Linoleic Acid (LA) Diet
- DIETARY_SUPPLEMENT Low Linoleic Acid (LA) Diet
Study Locations (1)
North Carolina
- Wake Forest Baptist Medical Center - Winston-Salem
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2016-11-29 |
| Est. Completion | 2021-12-14 |
| Phase | NA |
What the finished NCT02962128 record still lists
NCT02962128 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 1 condition, with Fatty Acid-Gene Interactions appearing as the primary indexed condition, and to 2 interventions - of which High Linoleic Acid (LA) Diet is the first listed.
NCT02962128 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT02962128 about?
NCT02962128 is a clinical study titled "Role of Polyunsaturated Fatty Acids (PUFA)-Gene Interactions in Heath Disparities". A randomized, clinical trial to provide the first comprehensive investigation of the role of fatty acid desaturate (FADS) genetic determinants on PUFA biosynthesis and metabolism as well as levels of inflammatory markers in a controlled dietary environment using two (low and high linoleic acid) para...
What is the current status of trial NCT02962128?
This trial is currently completed. It is a NA study. The enrollment target is 80 participants. The study started on 2016-11-29. Estimated completion is 2021-12-14.
What conditions does trial NCT02962128 study?
This clinical trial studies the following conditions: Fatty Acid-Gene Interactions.
What interventions are being tested in trial NCT02962128?
The interventions under investigation include: High Linoleic Acid (LA) Diet (DIETARY_SUPPLEMENT), Low Linoleic Acid (LA) Diet (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02962128?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02962128 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02962128's enrollment target sits among peer trials
80 994th of 2000 higher than 941 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI